Protoberberine alkaloids have demonstrated therapeutic effects on chronic atrophic gastritis and GC by activating IL-4/STAT6 pathway (120)IL-4 inhibited proliferation of HTB-135 GC cells by down-regulating G0-G1 cell cycle nuclear-regulating factors (121). Here, IL4 is linked to chronic atrophic gastritis.